ELVN Stock | Today, Tuesday 13 May 2025 The Dow Jones Industrial Average (DJIA) opened -0.43 percent lower at 42226.72, compared to 42410.10 points at the previous Wall Street close.
On Tuesday 13 May 2025 The S & P 500 index opened 0.75 percent higher at 5888.14 points, compared to 5844.19 points at the previous market close.
However, today Tuesday 13 May 2025 New York-based tech-heavy Nasdaq Composite index opened 1.45 percent higher at 18983.61 points till 1.36 PM, compared to 18708.34 at the previous US market close.
The small-cap U.S. stock market Russell 2000 Index opened 0.56 percent higher at 2104.00, compared to 2092.20 points at the previous Wall Street close.
Tuesday 13 May 2025 – ELVN Stock Price
Today, Tuesday 13 May 2025, the Enliven Therapeutics, Inc. stock is in news and the counter opened at $19.17, rising by 5.61 percent compared to the previous close. The stock price touched an intraday high of $20.25, while the intraday low was at $18.82. Enliven Therapeutics, Inc. stock recorded a 52-week high of $30.01 and a 52-week low of $13.3. The trading volume is 113,580 stocks, while the average trading volume stood at 284,641 on Tuesday 13 May 2025 till 1.36 PM.
According to the index, at time of writing (1.36 PM on Tuesday 13 May 2025), Enliven Therapeutics, Inc. (NASDAQ: ELVN) market cap is $991.62M USD. However, the intraday trading range of ELVN stock is $ $18.82 – $20.25 till 1.36 PM. Enliven Therapeutics, Inc.’s total debt as of Tuesday 13 May 2025 is 0 USD.
Enliven Therapeutics, Inc. Stock Technical Analysis
Enliven Therapeutics, Inc. EMA and SMA
Today, Tuesday 13 May 2025, SMA (Simple Moving Average) and EMA (Exponential Moving Average) over a short span of 5 days, SMA stands at 18.8, while the EMA is noted at 18.9.
Over 10 days, the SMA is 19.2, while the EMA is 18.9. The 20-day SMA stands at 18.3 compared to the EMA of 18.8.
For longer periods, the 50-day SMA is 19.3, and the 100-day SMA is -20.7, with the EMA at -20.5. However, the 200-day SMA is -22.8, with the EMA at -21.2 till Tuesday 13 May 2025.
Enliven Therapeutics, Inc. Key Resistance and Support Levels
The first key resistance is at 19.7 and first support is at 18.5. The second key resistance is at 20.4 and second support is at 17.9. However, the third key resistance is at 20.9 and third support is at 17.2.
Today, Tuesday 13 May 2025 keep an eye on these levels as the trading day progresses, as they offer very important insights into potential stock market movements every day.
Tuesday 13 May 2025 – Return delivered by ELVN Stock
Since today, Tuesday 13 May 2025, over the last 1-year period ELVN Stock price has delivered a negative return of -17.48% to investors.
However, on a Year-To-Date (YTD) basis, ELVN Stock has delivered a negative return of -10.18% to investors.
Over the last 3-years and 5-years period from Tuesday 13 May 2025, ELVN Stock has respectively delivered a 1,627.35% and -6.91% return to investors.
Forecaster – Wall Street Analyst Target and Estimates for Enliven Therapeutics, Inc.
- Out of the 14 analysts tracking this stock, 7 recommend Strong Buy.
- Out of the 14 analysts tracking this stock, 7 recommend BUY.
As of Tuesday 13 May 2025, the average target price for Enliven Therapeutics, Inc. is $38 with a high estimate of $42 and a low estimate is $33.
